Immune response that protects against infections also drives HIV latency

An immune response that likely evolved to help fight infections appears to be the mechanism that drives human immunodeficiency virus (HIV) into a latent state, lurking in cells only to erupt anew, researchers at Duke Health report.

Novel Amyloid Drug Improves Mid-Term Outcomes in ATTR Cardiomyopathy

AMSTERDAM — Novel anti-amyloid agent acoramidis improved a composite of outcome endpoints in the pivotal ATTRibute-CM trial for transthyretin mediated amyloidosis (ATTR) cardiomyopathy, with suggestion

August 30, 2023

FDA lays out postmarketing approaches for data collection from underrepresented groups

The FDA on Thursday published draft guidance on considerations for postmarket studies on populations that were underrepresented in premarket trials. The agency tells sponsors to

August 11, 2023

Opinion | Here’s What It Will Take to Grow HIV-Positive to HIV-Positive Transplant Access

Hemmige is an infectious disease specialist. In late November, HHS issued a final rule updating transplant regulations to enable every U.S. transplant center to transplant

January 15, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.